- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04385927
Life Beyond Trauma: 1-on-1 e-Health Program for Parents of Neurodiverse Children
Parents of neurodiverse children are more likely to experience traumatic events related to the care of their child/children. This increases the probability to experience Posttraumatic Stress Injury (PTSI). However, interventions addressing PTSI symptoms in parents are rare.
In this research project the study investigators will test the feasibility and efficacy of e-NET, a distance-delivered, exposure-based intervention for PTSI adapted to the needs of parents of neurodiverse children. E-NET is an adapted version of the Narrative Exposure Therapy (NET), an evidence-based intervention approach for individuals with PTSI who have experienced repeated or continuous trauma. The intervention will be conducted via videoconferencing with trained paraprofessionals. During the intervention a narrative of both positive and negative (traumatic) experiences in the parents' life will be created. The intervention contains approx. 12 one-on-one sessions with a trained paraprofessional via videoconferencing.
The study design is a waitlist control group design. Approx. 20 participants will receive e-NET directly after the baseline survey and 20 participants will receive e-NET approx. 3 months after the baseline survey. To test the efficacy of the intervention, participants will fill out surveys about PTSI and other mental health symptoms before, directly after, and 2 and 6 months after the intervention. Adverse events and distress will be assessed in every session. As part of the baseline, participants will complete the survey "Surviving and Thriving in Parenting Neurodiverse Children" to determine their eligibility for the intervention. Main eligibility criterion is the presence of PTSI symptoms.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3K6R8
- IWK Health Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Parent/Caregivers must meet the following criteria to be eligible to move on to Consent
- Be a parent/caregiver of a neurodiverse child
- Be at least 18 years of age
- Be able to understand spoken and written English at a Grade 8 level
- Fulfill the criteria of full or subclinical PTSI according to DSM-5, measured with the Life Events Checklist for DSM-5, the Parent Trauma Checklist and the PTSD Checklist for DSM-5. For this they have to report at least one traumatic event in the LEC-5 or the Stressful Life Experiences of Parents Checklist. To fulfill all PTSI criteria, the participant additionally needs to respond with "moderately" or higher in at least one item for the criteria B and C and two items for criteria D and E. Subclinical PTSI is fulfilled if the participant meets all but one criterion of B, C, D, or E is not met.
- Have access to a computer with high speed Internet
- Live in Canada
- Commit to the requirements of taking part in the study (12 weekly coaching calls)
Exclusion Criteria:
- Acute suicidal behavior or other extreme forms of self-destructive behavior
- Moderate to severe symptoms of dissociation
- Acute psychotic symptoms
- Previously participated in exposure intervention for PTSI/PTSD
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate e-NET Group
Parents of neurodiverse children with PTSI will receive e-NET immediately after the baseline survey
|
One-on-one distance coached intervention; approx.
12 sessions at 60-90 minutes.
|
Experimental: Wait List Control Group
Parents of neurodiverse children with PTSI will receive e-NET 3 months after the baseline survey
|
One-on-one distance coached intervention; approx.
12 sessions at 60-90 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in PTSI symptoms
Time Frame: Baseline, Immediately Post- intervention, 2 months post-intervention, 6 months post-intervention
|
PTSD symptoms are measured with the PTSD Checklist - 5 (PCL-5).
Respondents are asked to rate how bothered they have been by each of 20 items in the past month on a 5- point Likert scale ranging from 0-4.
Items are summed to provide a total severity score.
Higher scores indicate a worse outcome
|
Baseline, Immediately Post- intervention, 2 months post-intervention, 6 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Overall Health
Time Frame: Baseline, Wait-list Baseline; through study completion, an average of 12 weeks; Immediately Post-assessment; 2 month follow up; 6 month follow up
|
General health will be measured with the questionnaire PROMIS Global Health Caregiver's general health
|
Baseline, Wait-list Baseline; through study completion, an average of 12 weeks; Immediately Post-assessment; 2 month follow up; 6 month follow up
|
Change in Depression Symptoms
Time Frame: Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
|
Depression symptoms will be measured with the Patient Health Questionnaire (PHQ-9)
|
Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
|
Change in overall functionality
Time Frame: Baseline; Wait list Baseline, Immediately Post intervention; 2 month follow up; 6 month follow up
|
Functionality will be measured with the Sheehan Disability Scale (SDS).
SDS is measured on a 10-point scale (0-9).
Higher score indicates a worse outcome.
|
Baseline; Wait list Baseline, Immediately Post intervention; 2 month follow up; 6 month follow up
|
Posttraumatic Growth
Time Frame: Baeline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
|
Posttraumatic growth will be measures using the Posttraumatic Growth Inventory - Short Form (PTGI ).
The PTGI is measured on a 6-point Likert scale (score 0-5).
Higher score indicates a better outcome.
|
Baeline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
|
Parent-child Relationship
Time Frame: Baseline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
|
The parent-child relationship will be measured with the Parent and Family Adjustment Scales (PAFAS).
Items are rated from 0 to 3. Note that shaded items in the scoring key below must be reverse scored (i.e.
0=3, 1=2, 2=1, 3=0) before summing the Total Score.
High scores indicate worse outcome.
|
Baseline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
|
Satisfaction with Lifeline Tool
Time Frame: During week 1 of intervention
|
The satisfaction with Lifeline Tool (self-constructed) will be measured with a self-constructed 3-item usability questionnaire.
It is scored on a five point scale.
Items are rated from 0-4.
Higher score indicates better outcome.
|
During week 1 of intervention
|
Change in Anxiety Symptoms
Time Frame: Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
|
Anxiety Symptoms are measured with the Generalized Anxiety Disorder (GAD-7).
Items are scored on a four point scale, items are rated from 0-3.
Higher score indicates better outcome.
|
Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
|
Change in Physical Health Symptoms
Time Frame: Baseline; throughout study completion, approximately 12 week; Immediately Post-assessment; 2 month follow up; 6 month follow up
|
Physical Health symptoms will be assessed with the Patient Health Questionnaire Physical Symptoms (PHQ-15).
Items are scored on a three point scale, items are rated from 0-2.
Higher score indicates worse outcome.
|
Baseline; throughout study completion, approximately 12 week; Immediately Post-assessment; 2 month follow up; 6 month follow up
|
Adverse Events
Time Frame: throughout study completion, approximately 12 weeks; immediately post intervention
|
Adverse events will be assessed with a self-constructed questionnaire for adverse events, the course of symptoms during intervention and general distress.
|
throughout study completion, approximately 12 weeks; immediately post intervention
|
Therapeutic Alliance
Time Frame: Immediately post intervention
|
The interaction between coach and client will be assessed through the Therapeutic Alliance- Working Alliance Inventory - Short Form Revised (WAI-SR)
|
Immediately post intervention
|
Participant Satisfaction
Time Frame: Immediately Post intervention
|
Client satisfaction will be assessed with the Client Satisfaction Questionnaire (CSQ-8) and some additional (self-constructed) qualitative questions.
CAQ-8 Items are scored on a four point scale, items are rated from 0-3.
Higher score indicates worse outcome.
|
Immediately Post intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Patrick McGrath, PhD, IWK Health Centre
- Principal Investigator: Elisa Kaltenbach, PhD, IWK Health Centre
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23865
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Traumatic Stress Disorder
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
University of California, Los AngelesRecruitingPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
University of ZurichCompletedPost Traumatic Stress Disorder (PTSD) | Complex Post-Traumatic Stress Disorder (CPTSD)Switzerland
-
University of NottinghamNottinghamshire Healthcare NHS Trust; Lincolnshire Partnership NHS Foundation...CompletedDomestic Violence | Trauma, Psychological | Post-Traumatic Stress Disorder in Children | Narrative Exposure Therapy | Post-Traumatic Stress Disorder in Adolescence | Post-Traumatic Stress Disorder ComplexUnited Kingdom
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
-
Direction Centrale du Service de Santé des ArméesRecruitingPost-traumatic Stress DisorderFrance
-
VA Greater Los Angeles Healthcare SystemUniversity of California, Los AngelesRecruitingPost-Traumatic Stress DisorderUnited States
Clinical Trials on e-Net for Parents of Neurodiverse Children
-
Universidad Autonoma de San Luis PotosíHospital General de Soledad de Graciano Sánchez, SLP, MXCompleted
-
University of NottinghamNottinghamshire Healthcare NHS Trust; Lincolnshire Partnership NHS Foundation...CompletedDomestic Violence | Trauma, Psychological | Post-Traumatic Stress Disorder in Children | Narrative Exposure Therapy | Post-Traumatic Stress Disorder in Adolescence | Post-Traumatic Stress Disorder ComplexUnited Kingdom
-
Massachusetts General HospitalCompleted
-
University of WashingtonNational Center for Advancing Translational Sciences (NCATS)Not yet recruitingParenting | Mental Health Wellness 1 | Well-Being, Psychological
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingConduct Disorder | Autism-Spectrum DisorderSwitzerland
-
Centre Leon BerardInstitut d'Hématologie et d'Oncologie Pédiatrique; Fondation La Roche PosayNot yet recruitingAcute Lymphoblastic Leukemia, Pediatric
-
The University of Hong KongRecruitingEczema | Dermatitis, AtopicHong Kong
-
Chinese University of Hong KongRecruitingParent-Child Relations | Autism Spectrum DisorderHong Kong
-
University of Colorado, DenverNational Cancer Institute (NCI); Kaiser PermanenteCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Completed